Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Nephrotic Syndrome Market Size from 2025 to 2034?

The market size of nephrotic syndrome has been experiencing a swift expansion lately. It is predicted to increase from $0.87 billion in 2024 to $0.96 billion in 2025, with a compound annual growth rate (CAGR) of 10.7%. The past growth can be linked to the rising occurrence of nephrotic syndrome, escalation in genetic disorders, elevated obesity levels, heightened usage of immunosuppressive drugs, and the rising influence of genetic factors.

The market size for nephrotic syndrome is predicted to experience accelerated growth in the coming years. By 2029, it’s estimated to reach $1.43 billion with a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this expansion during the forecast period include increased awareness of nephrotic syndrome, escalating incidences of chronic kidney disease (CKD), rising prevalence of metabolic disorders and an aging population. Increased occurrence of autoimmune diseases is another contributing factor. Key trends in this forecast period are the use of telemedicine and remote monitoring, inventive drug delivery systems, progress in treatment methodologies, advancements in the field of biotechnology, and the incorporation of digital health technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21228&type=smp

What External and Internal Drivers Are Contributing to the Growth of theNephrotic Syndrome Market?

The rise in cases of kidney-related issues is projected to fuel the expansion of the nephrotic syndrome market. Such diseases encompass any conditions that inhibit the kidneys’ task of eliminating waste and excess fluids from the bloodstream, which are essential to the body’s overall health. The frequency of renal illnesses is growing due to elements such as diabetes, hypertension, obesity, an aging populace, and transformations in lifestyle, like insufficient hydration and excessive sodium consumption. Nephrotic syndrome exacerbates renal health problems by damaging the glomeruli, thereby undermining the kidneys’ capacity to discard waste and hold crucial proteins. For example, the Australian Institute of Health and Welfare, a government organization based in Australia, reported in June 2024 that the death rate due to chronic kidney disease (CKD) in Australia rose from 4.2% in 2021 to 6.2% in 2022. Consequently, the escalating frequency of renal diseases is propelling the growth of the nephrotic syndrome market.

What Segment Types Define the Nephrotic Syndrome Market Structure?

The nephrotic syndromemarket covered in this report is segmented –

1) By Type: Drugs; Devices

2) By Diagnosis Tests: Urinalysis; Glomerular Filtration Rate (GFR); Blood Test; Kidney Biopsy; Computerized Tomography (CT) Scan

3) By Application: Clinics; Hospitals; Speciality Centres; Other Applications

Subsegments:

1) By Drugs: Steroids; Immunosuppressants; Diuretics; ACE Inhibitors Or ARBs; Other Drugs

2) By Devices: Dialysis Machines; Peritoneal Dialysis Catheters; Hemodialysis Catheters; Kidney Replacement Therapy Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21228&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Nephrotic Syndrome Market?

North America was the largest region in the nephrotic syndrome market in 2024. The regions covered in the nephrotic syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Nephrotic Syndrome Market?

The nephrotic syndrome market’s leading corporates are now prioritizing the creation of new treatments such as loop diuretic injections that enhance fluid handling and reduce edema in patients suffering from nephrotic syndrome. The term “loop diuretic Injection” denotes a medicine administered by injection that blocks the reabsorption of sodium and chloride at the loop of Henle, driving swift urine production. Its applications include the treatment of diseases like acute pulmonary edema, heart failure and severe hypertension, by way of limiting fluid overload. For example, in March 2024, a U.S. pharmaceutical company called Avenacy Inc. introduced into the U.S. market a product called furosemide for injection, which is a generic equivalent of Lasix, a drug sanctioned by the Food and Drug Administration to address edema related to heart failure, cirrhosis of the liver and kidney diseases. This product, packaged in 25 packs containing 10 mL doses of 100 mg, forms part of Avenacy’s larger strategy of extending its offering of injectable medications, with an ambition to launch more than 20 new products in 2024. The drug is designed to treat both adults and children suffering from edema linked with conditions like congestive heart failure, liver cirrhosis, kidney disorders and nephrotic syndrome.

View the full report here:

https://www.thebusinessresearchcompany.com/report/nephrotic-syndrome-global-market-report

What Is the Definition of the Nephrotic Syndrome Market?

Nephrotic syndrome is a kidney disorder characterized by excessive protein loss in the urine (proteinuria), low levels of protein in the blood (hypoalbuminemia), high cholesterol levels (hyperlipidemia), and swelling (edema), especially in the legs, feet, and around the eyes. It occurs due to damage to the glomeruli, the kidney’s filtering units, which allows the protein to leak into the urine.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21228

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model